Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study

Atara Biotherapeutics said a patient in an early-stage study of its CAR-T cell therapy has died. The biotech and the study sponsor are evaluating "the extent of the relationship" of the death to the treatment.